The most common question Bellissima patients ask once they have been on Botox for a year or two is some version of: how do I get this to last longer? Daxxify is the answer that has shifted the neuromodulator conversation in Frisco, TX over the last several years. Approved by the FDA in 2022 and offered at Bellissima BB Med Spa alongside Botox and Xeomin, Daxxify is a peptide-formulated neuromodulator designed to extend results from the standard 12 to 16 weeks of Botox to roughly 6 to 9 months for many patients. Carm San, BSN, RN evaluates Daxxify candidacy during consultation and explains the tradeoffs in plain language. This guide walks through what makes Daxxify different, who actually benefits most from it, and how it fits into a long-term Botox plan.
Daxxify is not the right answer for every patient. It is, however, often the right answer for patients with packed schedules, frequent travel, or a strong preference for fewer appointments per year. Patients from across Frisco, McKinney, Plano, Allen, and the broader North Dallas area increasingly request it specifically.
Daxxify uses the same core active ingredient as Botox and Xeomin — a purified form of botulinum toxin type A — but the formulation is different in one important way. Daxxify is stabilized by a proprietary peptide rather than the human or animal-derived proteins used in older neuromodulators. This peptide structure appears to help the active ingredient bind more effectively to muscle receptors, which is the mechanism most likely responsible for its extended duration.
The U.S. Food and Drug Administration's approval announcement outlines the original clinical use case (moderate to severe glabellar lines) and the trial data showing improved duration. Subsequent off-label and peer practice has expanded the use to other facial areas with similar dosing principles.
For patients, the practical takeaways are straightforward. Daxxify produces the same kind of wrinkle softening as Botox and Xeomin. The visible result is similar. The differentiator is how long it stays. Most Bellissima patients report seeing results extend toward five to seven months, with a subset experiencing the full eight to nine months reported in clinical trials.
Daxxify is well-suited for several specific patient profiles:
Daxxify is not the best fit for first-time neuromodulator patients. The reason is practical: when you do not yet know how your face responds to a neuromodulator, a longer-lasting option is harder to fine-tune. If the dosing is slightly heavy or light, you wait six to nine months for it to wear off rather than three to four. Most patients are better off establishing a baseline with Botox first.
Carm wrote a detailed comparison in her Botox vs Xeomin vs Daxxify guide, which is the best place to start if you want a side-by-side breakdown. The short summary for Daxxify specifically:
The American Society of Plastic Surgeons publishes a useful comparison overview that aligns with what Bellissima patients tend to experience clinically.
The most common misunderstanding patients arrive with is the assumption that Daxxify automatically lasts nine months. The clinical trial data showed that 80 percent of patients had minimal or no glabellar lines four months after treatment, and a subset extended results closer to six months. Real-world experience varies more widely than the trial data suggests.
Three factors influence how long Daxxify actually lasts in practice:
The honest answer Carm gives during consultation is that Daxxify usually lasts noticeably longer than Botox — often 1.5 to 2x — but the exact duration depends on you. The first cycle establishes your baseline. From there, planning becomes predictable.
For most patients, the question is not whether to use Daxxify exclusively or Botox exclusively, but how to build a plan that uses each at the right time. A common pattern at Bellissima looks like this:
Patients enrolled in the Bellissima Beauty Membership often discuss product strategy with Carm during their regular check-ins and adjust the plan as their schedule and aesthetic goals evolve.
The switch is not a clean cutover. Your existing Botox needs to fully wear off before Daxxify is administered, which means timing the first Daxxify appointment for the back half of your normal Botox cycle (typically week 12 to 14). Carm recommends:
If you have not had Botox in over a year, you can start directly with Daxxify, but Carm typically still recommends a baseline cycle of Botox first to confirm dosing patterns.
The Daxxify appointment itself is essentially identical to a Botox visit — same consultation flow, same injection technique, same aftercare. The differences are subtle:
Most patients return to their day immediately. Daxxify is not a more invasive treatment than Botox — the molecular formulation is what differs, not the experience of receiving it.
Carm's approach to Daxxify mirrors her broader injectable philosophy: conservative, anatomy-driven, and focused on natural-looking results. The 30+ years of clinical experience that informs her Botox dosing applies directly to Daxxify dosing — the technique is the same, the product is just engineered to last longer.
Patients who want to read more about Carm's clinical background can review her training and credentials. The full Botox treatment menu includes Daxxify as a standard option.
Whether you are switching from Botox or considering Daxxify as your first neuromodulator, the consultation is where the right plan gets mapped. Carm reviews your aesthetic goals, treatment history, lifestyle, and budget before recommending a product strategy.
Bellissima BB Med Spa
Mattison Salon Suites & Spa
7777 Warren Pkwy #200, Suite 122
Frisco, TX 75034
Phone: (214) 392-9897
Book a Daxxify consultation in Frisco to find out whether the longer-lasting option fits your goals — or browse the rest of our injectables blog for more context first.
Most patients see results last between 5 and 7 months, with some experiencing the full 8 to 9 months reported in clinical trials. Individual response varies based on metabolism, muscle strength, and dosing. The first Daxxify cycle establishes your personal baseline.
All three FDA-approved neuromodulators (Botox, Xeomin, Daxxify) have strong long-term safety records when administered by a credentialed medical professional. Daxxify is not safer or riskier than Botox — it is simply formulated differently for extended duration. The American Academy of Dermatology's guidance on neuromodulators applies to all three.
Yes. Switching between neuromodulators is straightforward. Once Daxxify wears off (typically 5 to 9 months after treatment), you can resume Botox or Xeomin on your normal cycle. There is no withdrawal or rebound effect from switching.
Daxxify carries a higher per-unit price because each unit is delivering longer-lasting results. When you calculate cost per month rather than per visit, Daxxify often lands close to Botox or Xeomin in total annual spend.
The visible result is essentially the same kind of wrinkle softening. If you have been happy with how Botox looks on your face, Daxxify will produce a similar appearance — just for a longer duration. Carm calibrates dosing to your established Botox baseline when switching products.
Like all neuromodulators, Daxxify is not reversible — it wears off rather than being neutralized. The longer duration means a small adjustment issue takes longer to resolve. This is why Carm typically recommends Daxxify for established neuromodulator patients who already know their dosing patterns, not for first-time injectables.
Daxxify often shows initial effect in 1 to 2 days, faster than Botox's typical 4 to 7 days. Peak results appear at the 14-day mark for both products.
For patients who value fewer appointments per year, the answer is usually yes. For patients who appreciate the predictability of quarterly visits and the ability to fine-tune dosing more frequently, Botox often remains the better choice. Carm helps map this decision during consultation based on your specific lifestyle and goals.
